Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch Orion, a cloud platform, running on google cloud architecture; and EpiSwitch Explorer Array Kit platform, enabling advanced analysis of 3D regulatory control points. The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

CEO

Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D

Employees

Country

United Kingdom

ISIN

GB00BD5H8572

Listings

0 Comments

Share your thoughts

FAQ

What is Oxford BioDynamics stock price today?▼

The current price of LMQ.STU is €0 EUR — it has increased by +0% in the past 24 hours. Watch Oxford BioDynamics stock price performance more closely on the chart.

What is Oxford BioDynamics stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Oxford BioDynamics stocks are traded under the ticker LMQ.STU.

Is Oxford BioDynamics stock price growing?▼

LMQ.STU stock has risen by +0% compared to the previous week, the month change is a -0% fall, over the last year Oxford BioDynamics has showed a -66.67% decrease.

When is the next Oxford BioDynamics earnings date?▼

Oxford BioDynamics is going to release the next earnings report on June 23, 2026.

What were Oxford BioDynamics earnings last quarter?▼

LMQ.STU earnings for the last quarter are -0.01 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.

How many employees does Oxford BioDynamics have?▼

As of May 06, 2026, the company has 41 employees.

In which sector is Oxford BioDynamics located?▼

Oxford BioDynamics operates in the Health & Wellness sector.

When did Oxford BioDynamics complete a stock split?▼

Oxford BioDynamics has not had any recent stock splits.

Where is Oxford BioDynamics headquartered?▼

Oxford BioDynamics is headquartered in Oxford, United Kingdom.